Trial watch: dendritic cell vaccination for cancer immunotherapy

Dendritic- cells (DCs) have received considerable attention as potential targets for the development of anticancer vaccines. DC-based anticancer vaccination relies on patient-derived DCs pulsed with a source of tumor-associated antigens (TAAs) in the context of standardized maturation-cocktails, fol...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncoimmunology
Main Authors: Sprooten, Jenny, Ceusters, Jolien, Coosemans, An, Agostinis, Patrizia, De Vleeschouwer, Steven, Zitvogel, Laurence, Kroemer, Guido, Galluzzi, Lorenzo, Garg, Abhishek D.
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis 2019
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6791419/
https://ncbi.nlm.nih.gov/pubmed/31646087
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2019.1638212
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados